CIK: 1443159 - Address: C/o Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA 94158
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret116-2113612208
S%wins6750335033039

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/17/19 20:19
5/16/19
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS-7731.370-2-395D
2/21/19 20:13
2/19/19
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS-10142.390-2-297D
11/19/18 18:12
11/16/18
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS-18038.250-5-581D
5/18/18 19:02
5/16/18
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS-33983.390-4-576D
4/12/18 18:05
4/10/18
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharM.d47.2101180D
4/12/18 18:05
4/10/18
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS.d-53105.670-1-180D
4/9/18 20:22
4/5/18
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharM.dm2137.210295880D
4/9/18 20:22
4/5/18
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS.dm-3,033102.810-29-2780D
2/20/18 19:07
2/16/18
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS-23882.940-3-380D
11/8/17 18:02
11/6/17
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharM.dm68117.1504021558D
11/8/17 18:02
11/6/17
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS.d-12825.070-5-858D
10/10/17 18:07
10/5/17
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharM.d8110.69081558D
10/10/17 18:07
10/5/17
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS.d-19025.000-8-1258D
8/18/17 19:03
8/16/17
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS-5719.320-3-558D
5/18/17 20:47
5/16/17
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS-5819.5531-3-561D80514548-165712
4/7/17 18:05
4/5/17
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharM.d2,46613.703318064D893923595636-12-7-8-7-10
4/7/17 18:05
4/5/17
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS.d-3,90621.7033-180-7464D893923595636-12-7-8-7-10
2/17/17 20:04
2/16/17
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS-2913.1414-2-364D-514-27-7-25-1-22369
11/18/16 18:09
11/16/16
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS-2313.9629-2-350D-1-71-19-17167-3-3-3-7-4
8/17/16 17:38
8/16/16
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS-5817.5620-3-652D30534731231502039-19-23
5/18/16 17:13
5/16/16
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharM.d00.0001142447D2218-112-13-1802-2710296
5/18/16 17:13
5/17/16
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS.d-1113.5814-1-107D2218-112-13-1802-2710296
2/18/16 19:45
2/16/16
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharM.d00.0001262606D-11-134-11-26-1705108175220
2/18/16 19:45
2/17/16
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsHora ManinderCAOSVP PharS.d-1111.9226-1-146D-11-134-11-26-1705108175220

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact